We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $281M
1-Year Est. Return 261.03%
This Fund
S&P 500
This Quarter Est. Return
-5.74%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow %
101.7%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$13.4M
2
VRNA
Verona Pharma
VRNA
+$11.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBRV
1
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$12.7M 12.6%
+8,492
New +$13.4M
VRNA
2
DELISTED
Verona Pharma
VRNA
$10.4M 10.31%
+875,000
New +$11.4M

Similar funds

FFP
Freedom Financial Partners Oakdale, Minnesota $281M AUM 16.89% 1-Year Est. Return
BDA
Borer Denton & Associates Blue Bell, Pennsylvania $280M AUM 7.09% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
ACC
Acorn Creek Capital Fort Collins, Colorado $280M AUM 19.97% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
IP
Investment Partners New Philadelphia, Ohio $281M AUM 20.9% 1-Year Est. Return

venBio Partners's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for venBio Partners, which disclosed 3 positions worth $101M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Nabriva Therapeutics plc Ordinary Shares Ireland: 8,492 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets.

  • venBio Partners's largest Q4 2017 buy was Nabriva Therapeutics plc Ordinary Shares Ireland: 8,492 shares worth $12.7M.
  • venBio Partners's ten largest holdings make up 100% of its $101M portfolio in Q4 2017.
  • venBio Partners disclosed 3 positions in Q4 2017, its first 13F filing on record.

Based on venBio Partners's 13F filing for Q4 2017, filed 25 Apr 2018.